These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11286608)

  • 1. Enteral suspension of nifedipine for neonates. Part 2. Stability of an extemporaneously compounded nifedipine suspension.
    Helin-Tanninen M; Naaranlahti T; Kontra K; Ojanen T
    J Clin Pharm Ther; 2001 Feb; 26(1):59-66. PubMed ID: 11286608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteral suspension of nifedipine for neonates. Part 1. Formulation of nifedipine suspension for hospital use.
    Helin-Tanninen M; Naaranlahti T; Kontra K; Wallenius K
    J Clin Pharm Ther; 2001 Feb; 26(1):49-57. PubMed ID: 11286607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of nifedipine in an extemporaneously compounded oral solution.
    Dentinger PJ; Swenson CF; Anaizi NH
    Am J Health Syst Pharm; 2003 May; 60(10):1019-22. PubMed ID: 12789873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particular features of photolabile substances in tablets.
    Aman W; Thoma K
    Pharmazie; 2003 Sep; 58(9):645-50. PubMed ID: 14531462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stability of quetiapine oral suspension compounded from commercially available tablets.
    Tran J; Gervase MA; Evans J; Deville R; Dong X
    PLoS One; 2021; 16(8):e0255963. PubMed ID: 34375349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photochemical stabilities of some dihydropyridine calcium-channel blockers in powdered pharmaceutical tablets.
    Kawabe Y; Nakamura H; Hino E; Suzuki S
    J Pharm Biomed Anal; 2008 Jul; 47(3):618-24. PubMed ID: 18339506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of an extemporaneously compounded minoxidil oral suspension.
    Song Y; Chin ZW; Ellis D; Lwin EMP; Turner S; Williams D; Garg S
    Am J Health Syst Pharm; 2018 Mar; 75(5):309-315. PubMed ID: 29472513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of nifedipine in two oral suspensions stored at two temperatures.
    Nahata MC; Morosco RS; Willhite EA
    J Am Pharm Assoc (Wash); 2002; 42(6):865-7. PubMed ID: 12482010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical and Microbiological Stability of Compounded Bethanechol Chloride Oral Suspensions in PCCA Base, SuspendIt®.
    Pramar YV; Davis C; Ip K; Banov D
    Int J Pharm Compd; 2024; 28(4):321-328. PubMed ID: 39094044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an extemporaneous liquid formulation of lisinopril.
    Thompson KC; Zhao Z; Mazakas JM; Beasley CA; Reed RA; Moser CL
    Am J Health Syst Pharm; 2003 Jan; 60(1):69-74. PubMed ID: 12533979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of an Extemporaneously Compounded Oral Suspension of Bosentan.
    Malik A; Gorman G; Coward L; Arnold JJ
    Hosp Pharm; 2016 May; 51(5):389-95. PubMed ID: 27303093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes.
    McHenry AR; Wempe MF; Rice PJ
    Int J Pharm Compd; 2017; 21(3):251-254. PubMed ID: 28557788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Content uniformity and stability of nifedipine in extemporaneously compounded oral powders.
    Helin MM; Kontra KM; Naaranlahti TJ; Wallenius KJ
    Am J Health Syst Pharm; 1998 Jun; 55(12):1299-301. PubMed ID: 9640472
    [No Abstract]   [Full Text] [Related]  

  • 14. Stability of extemporaneously prepared cinacalcet oral suspensions.
    Thomson K; Hutchinson DJ; Chablani L
    Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.
    Cober MP; Johnson CE
    Am J Health Syst Pharm; 2007 Mar; 64(6):644-6. PubMed ID: 17353574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C.
    Nahata MC; Morosco RS; Trowbridge JM
    Am J Health Syst Pharm; 2000 Jun; 57(12):1141-3. PubMed ID: 10911513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of clonidine suspension in oral plastic syringes.
    Ma C; Decarie D; Ensom MH
    Am J Health Syst Pharm; 2014 Apr; 71(8):657-61. PubMed ID: 24688040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of extemporaneously prepared moxifloxacin oral suspensions.
    Hutchinson DJ; Johnson CE; Klein KC
    Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt.
    Pramar YV; Mandal TK; Bostanian LA; Kader C; Morris TC; Graves RA
    Int J Pharm Compd; 2021; 25(5):431-439. PubMed ID: 34623970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions.
    Li Q; Liu Z; Kolli S; Wetz K; Griffith N; Poi MJ
    Am J Health Syst Pharm; 2016 Sep; 73(17):1331-7. PubMed ID: 27543577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.